Brief: Xintela Completes Clinical Study With Xstem In Knee Osteoarthritis
15/08/2025 07:14
Aug 15 (Reuters) - Xintela AB XINT.ST: COMPLETES CLINICAL STUDY WITH XSTEM IN KNEE OSTEOARTHRITIS XINTELA PREVIOUSLY COMMUNICATED POSITIVE INTERIM RESULTS UP TO 18 MONTHS AFTER TREATMENT AND NOW COMPLETED COLLECTION OF 24-MONTHS DATA FOR HIGHEST DOSE LEVEL Source text: ID:nMFN3M9pDH Further company coverage: XINT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))